ABG vs TSLA

ABG exhibits strong fundamental health with a Piotroski F-Score of 7/9, indicating robust accounting strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears undervalued relative to its Graham Number of $349.14 and intrinsic value of $801.22, trading at $238.04, but elevated leverage and weak technicals weigh on sentiment. Solid profitability metrics, double-digit revenue and earnings growth, and strong ROE contrast with insider selling and a bearish technical trend. Analysts concur with a 'hold' rating, aligning with mixed signals between value and sentiment.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.